BTX · Categories · Form 3

BTX - SEC Form 3 initial insider statements

BlackRock Technology and Private Equity Term Trust (BTX) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for BTX

• 390d
  New insider Minar Stephen Thomas claimed ownership of 1,967 shares (SEC Form 3)

  3 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 845d
  SEC Form 3 filed by new insider Cicala Peter

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 889d
  SEC Form 3 filed by new insider Luther Sanjeev

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 940d
  SEC Form 3 filed by new insider Bristol James Arthur

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1013d
  SEC Form 3 filed by new insider Clarke Dorothy J

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1065d
  SEC Form 3 filed by new insider Wagner Richard W

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1065d
  SEC Form 3 filed by new insider Binder Brant

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1163d
  SEC Form 3: New insider Freebird Partners Lp claimed ownership of 272,582 shares

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1464d
  SEC Form 3: New insider Singer Nicholas Jason claimed ownership of 2,095,000 shares

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1464d
  SEC Form 3 filed by new insider Wexler William A.

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1464d
  SEC Form 3 filed by new insider Fiore Gregory

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1470d
  SEC Form 3 filed by new insider Jackson Andrew C.

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1470d
  SEC Form 3: New insider Angel Matthew claimed ownership of 3,489,666 shares

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1603d
  SEC Form 3 filed by new insider Enright Erin S.

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1603d
  SEC Form 3 filed by new insider Redman Heather B

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1722d
  SEC Form 3 filed by new insider Sidhu Roger

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1787d
  SEC Form 3 filed by Sial Jay

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1806d
  SEC Form 3 filed by DAmour Kevin

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1814d
  SEC Form 3: Gurrola Sandra M claimed ownership of 8,203 units of Common Stock

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1841d
  SEC Form 3 filed by Mohr Erich

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1862d
  SEC Form 3 filed by LANGER DENNIS

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1877d
  SEC Form 3 filed by Federoff Howard J.

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1878d
  SEC Form 3: Cherington Charles claimed ownership of 6,294,101 units of Common Stock

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1878d
  SEC Form 3: DENNY GEORGE P III claimed ownership of 4,888,796 units of Common Stock

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1881d
  SEC Form 3: Monovoukas Yiannis claimed ownership of 1,681,359 units of Common Stock

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1892d
  SEC Form 3: Ronald Guido claimed ownership of 102,112 units of Common Stock

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1892d
  SEC Form 3: Sadowski Lynn Mason claimed ownership of 94,333 units of Common Stock

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1892d
  SEC Form 3: Luba Greenwood claimed ownership of 50,032 units of Common Stock

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1892d
  SEC Form 3: Jason Nicholas Singer claimed ownership of 3,791,983 units of Common Stock

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)

Other BTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends